Literature DB >> 2507289

Altered thyrotropin (TSH) carbohydrate structures in hypothalamic hypothyroidism created by paraventricular nuclear lesions are corrected by in vivo TSH-releasing hormone administration.

T Taylor1, B D Weintraub.   

Abstract

TSH is a glycoprotein hormone composed of two subunits with attached carbohydrate chains that have varying structural characteristics. To determine the role of TRH in vivo in regulating structural characteristics of TSH carbohydrate chains, adult rats received paraventricular nuclear (PVN) lesions (n = 6) or sham lesions (n = 6). The PVN contain large amounts of TRH, and rats with lesions in these hypothalamic nuclei have been shown to have decreased plasma thyroid hormone levels. At 10 days after surgery, sc osmotic pumps infusing saline or 1 mg/kg/day TRH were placed. At 14 days after surgery, pituitaries were removed and incubated with [3H]glucosamine for 24 h. Glycopeptides prepared from secreted TSH were sequentially eluted from Concanavalin-A chromatography columns selecting unbound, weakly bound, and strongly bound forms. Plasma free T4 was lower in the PVN lesioned rats treated with saline than sham lesioned rats treated with saline (1.6 +/- 0.4 vs. 5.2 +/- 0.1 ng/dl, P less than 0.001). In vivo TRH administration in the PVN lesioned group normalized plasma free T4 but had no effect on free T4 in the sham group. Secreted TSH glycopeptides in the PVN lesioned rats treated with saline as compared to sham lesioned rats treated with saline had fewer unbound forms reflecting multiantennary structures (43 +/- 4 vs. 57 +/- 1%; P less than 0.05) and more weakly bound forms reflecting biantennary structures (50 +/- 4 vs. 35 +/- 2%; P less than 0.05). TRH administration in vivo normalized the Concanavalin-A binding pattern of secreted TSH glycopeptides in the PVN lesioned group but had no significant effect in the sham lesioned group. TSH alpha-subunit demonstrated both multi- and biantennary forms but TSH-beta subunit showed a predominance of multiantennary forms in both the PVN and sham lesioned groups treated with saline. In vivo changes in TRH levels altered TSH carbohydrate characteristics as described above for both subunits. In summary, hypothalamic hypothyroidism altered TSH carbohydrate structures, and in vivo TRH administration normalized these structures in parallel with the correction of serum free T4. In addition to reported quantitative changes in TSH in response to TRH, these qualitative changes may have an important effect on TSH action.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2507289     DOI: 10.1210/endo-125-4-2198

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  Type 3 deiodinase is critical for the maturation and function of the thyroid axis.

Authors:  Arturo Hernandez; M Elena Martinez; Steven Fiering; Valerie Anne Galton; Donald St Germain
Journal:  J Clin Invest       Date:  2006-01-12       Impact factor: 14.808

2.  Tissue-specific posttranslational modification allows functional targeting of thyrotropin.

Authors:  Keisuke Ikegami; Xiao-Hui Liao; Yuta Hoshino; Hiroko Ono; Wataru Ota; Yuka Ito; Taeko Nishiwaki-Ohkawa; Chihiro Sato; Ken Kitajima; Masayuki Iigo; Yasufumi Shigeyoshi; Masanobu Yamada; Yoshiharu Murata; Samuel Refetoff; Takashi Yoshimura
Journal:  Cell Rep       Date:  2014-10-30       Impact factor: 9.423

3.  Critical role for thyroid hormone receptor beta2 in the regulation of paraventricular thyrotropin-releasing hormone neurons.

Authors:  E D Abel; R S Ahima; M E Boers; J K Elmquist; F E Wondisford
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

Review 4.  Central regulation of hypothalamic-pituitary-thyroid axis under physiological and pathophysiological conditions.

Authors:  Csaba Fekete; Ronald M Lechan
Journal:  Endocr Rev       Date:  2013-12-13       Impact factor: 19.871

5.  Thyrotropin with decreased biological activity, a delayed consequence of cranial irradiation for nasopharyngeal carcinoma.

Authors:  K O Lee; L Persani; M Tan; F X Sundram; P Beck-Peccoz
Journal:  J Endocrinol Invest       Date:  1995-11       Impact factor: 4.256

6.  alpha-Melanocyte-stimulating hormone is contained in nerve terminals innervating thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and prevents fasting-induced suppression of prothyrotropin-releasing hormone gene expression.

Authors:  C Fekete; G Légrádi; E Mihály; Q H Huang; J B Tatro; W M Rand; C H Emerson; R M Lechan
Journal:  J Neurosci       Date:  2000-02-15       Impact factor: 6.167

Review 7.  Thyrotropin-releasing hormone (TRH) in the cerebellum.

Authors:  Nobuyuki Shibusawa; Koshi Hashimoto; Masanobu Yamada
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

8.  Novel insight from transgenic mice into thyroid hormone resistance and the regulation of thyrotropin.

Authors:  E D Abel; H C Kaulbach; A Campos-Barros; R S Ahima; M E Boers; K Hashimoto; D Forrest; F E Wondisford
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

9.  Molecular economy of nature with two thyrotropins from different parts of the pituitary: pars tuberalis thyroid-stimulating hormone and pars distalis thyroid-stimulating hormone.

Authors:  Sibel Ertek
Journal:  Arch Med Sci       Date:  2021-01-05       Impact factor: 3.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.